Diffusion-MRI in neurodegenerative disorders

Joseph Goveas1, Laurence O'Dwyer2, Mario Mascalchi3

  • 1Department of Psychiatry and Behavioral Medicine, and Institute for Health and Society, Medical College of Wisconsin, Milwaukee, WI, USA.

Insights

Diffusion Magnetic Resonance Imaging (dMRI) offers sensitive brain imaging for detecting neurodegenerative diseases. This review explores dMRI

Area of Science:

  • Neuroimaging
  • Radiology
  • Neurology

Background:

  • Brain abnormalities in diseases are increasingly understood through advanced imaging techniques.
  • Diffusion Magnetic Resonance Imaging (dMRI) utilizes water molecule displacement as a sensitive contrast mechanism.
  • dMRI provides detailed structural information valuable in clinical and research settings.

Purpose of the Study:

  • To review the applications, findings, and challenges of dMRI in neurodegenerative disorders.
  • To explore the potential of dMRI as an imaging biomarker for early disease detection and monitoring.
  • To summarize current research and future directions for dMRI in understanding neurodegeneration.

Main Methods:

  • Review of existing literature on diffusion-MRI applications in neurodegenerative diseases.
  • Analysis of dMRI's role in characterizing microstructural changes and neurophysiological mechanisms.
  • Exploration of dMRI's utility as a quantitative imaging biomarker.

Main Results:

  • dMRI has demonstrated utility in understanding microstructural changes in various neurodegenerative conditions.
  • Quantitative indices from dMRI can serve as potential imaging biomarkers for early detection and tracking of disease progression.
  • The technique offers insights into the neurophysiological mechanisms underlying disorders like Alzheimer's, Parkinson's, and ALS.

Conclusions:

  • Diffusion-MRI is a powerful tool for investigating neurodegenerative disorders.
  • Its quantitative nature supports its use as an imaging biomarker for early detection and patient monitoring.
  • Further research is needed to fully leverage dMRI's potential in clinical trials and patient management.